The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Antibiotic resistance Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally... AseBio
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 We consider that improvements have been made regarding the original proposal, but these continue to be insufficient for... AseBio
Webinar: Preparing for IVDR Clinical Performance Studies Online Del 30/04/2024 17:00 to 30/04/2024 18:00 Healthcare Access to innovation In vitro diagnostics Personalized medicine The webinar will focu on the critical aspects of designing and conducting In Vitro Diagnostic (IVD) performance studies...
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications aimed at alleviating... AseBio
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Approximately 10,000 new cases of Parkinson's are detected each year in Spain, with a total figure exceeding 150,000... AseBio
Biotechnology lays the groundwork for the present and future of healthcare and drives the ... 07/04/2024 Healthcare Drug discovery Rare diseases Personalized medicine Advanced therapies Antibiotic resistance Climate change Agrifood Animal health The health pipeline of AseBio includes 130 molecules for 150 indications being investigated by 40 national companies... AseBio
Biotechnology lays the groundwork for the present and future of healthcare and drives the ... 07/04/2024 AseBio's health pipeline includes 130 molecules for 150 indications being researched by 40 national companies, with... AseBio
The Spanish AI Healthcare Landscape 04/04/2024 Healthcare Access to innovation Rare diseases Personalized medicine While not yet a global player, Artificial Intelligence (AI) is increasingly being integrated into the healthcare... Partners - OWKIN
Almirall signs licensing agreement with Eloxx Pharmaceuticals and enters the field of rare... 25/03/2024 Healthcare Access to innovation Rare diseases Personalized medicine Advanced therapies The Spanish pharmaceutical company has obtained global rights to develop and commercialize the drug ZKN-013. Partners - Almirall
Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the ... 20/03/2024 Healthcare Personalized medicine Financing Ysios Capital participates in the financing round for the capital increase of the US company Engrail Therapeutics. Partners - Ysios Capital Partners
